Article 01 May 2024 Federal Circuit Affirms Obviousness Of Rifaximin Polymorph Patents And Denial Of Motion To Modify Judgment After Post-Trial Patented Indication Carve Out United States IP
Article 25 Oct 2021 EXCLUSIVE RIGHTS: Intellectual Property — Don't Get Caught Double Patenting! (Podcast) United States IP
Article 11 Oct 2017 Canada Institutes Certificates Of Supplementary Protection For Approved Drug Products United States IP